Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Genes|February 13, 2019
Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the <i>Ha-Ras</i> OncogeneMichela Vitiello, Giuseppe Palma, Mario Monaco, et al.
Analytical and Bioanalytical Chemistry|October 27, 2012
Electrochemical detection of miRNA-222 by use of a magnetic bead-based bioassayFrancesca Bettazzi, Ezat Hamid-Asl, Carla Lucia Esposito, et al.
Bioactive Materials|May 9, 2025
A novel CD44-targeting aptamer recognizes chemoresistant mesenchymal stem-like TNBC cells and inhibits tumor growthAlessandra Caliendo, Simona Camorani, Luis Exequiel Ibarra, et al.
Advanced Healthcare Materials|February 12, 2025
Urine-Stable Aptamer-Conjugated Gold Nanorods for the Early Detection of High-Grade Bladder Cancer Residual DiseaseChiara Venegoni, Silvia Tortorella, Alessandra Caliendo, et al.
Oncotarget|September 24, 2017
PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtypeElia Guadagno, Michela Vitiello, Paola Francesca, et al.
Oncotarget|August 6, 2016
PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomasRenato Franco, Giosuè Scognamiglio, Elena Valentino, et al.
Molecules (Basel, Switzerland)|January 8, 2020
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-6Jean Jacques Vanden Eynde, Arduino A Mangoni, Jarkko Rautio, et al.
Molecules (Basel, Switzerland)|July 2, 2020
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-7Michael Gütschow, Jean Jacques Vanden Eynde, Josef Jampilek, et al.
Pageof 8